According to ABC News, insiders and consultants for Johnson & Johnson from across the globe have recently come forward to reveal how corrupt the company’s actions were in regards to the defective hip implant DePuy ASR.
Dr. Antoni Nargol, a consultant orthopedic surgeon at the University Hospital of North Tees in North England, is one of the surgeons who worked with DePuy to monitor the progress of the new hip implant device when it was first being tested.
Dr. Nargol stated the following in an interview with ABC News:
“A lot of the implants were not meeting the specification that they were meant to, so we put this to DePuy and we gave them some implants and said, ‘Look these are out of specification. Will you check them?’ And [Johnson & Johnson] came back and said, ‘We’ve looked at the implants and they’re fine.’ But what was interesting was that they weren’t fine. They’re absolutely not fine, but we were told they were.”
Johnson & Johnson Puts Profit Before People
Johnson & Johnson’s failure to manufacture a medical implant to correct specifications caused the product to shed harmful metal debris inside the victim’s body, injuring thousands of patients around the world, many of whom had to undergo further painful surgery to remove the device.
The DePuy ASR was marked in two versions: as a hip replacement prosthesis and as a hip resurfacing implant. However, only the total hip replacement version was authorized by the Food and Drug Administration to be used in the US.
The device was designed, manufactured and marketed by DePuy International, a subsidiary of Johnson & Johnson, the world’s largest medical devices company. Nearly 100,000 patients around the world were implanted with the device.
DePuy announced a worldwide recall of the device in August of 2010, after medical officials noticed surgeries in patients to remove the ASR device were far higher than they should be.
The widespread failure of the ASR implant was largely hidden from surgeons by DePuy.
Did You Know: According to a study released in March 2011 in England, 49 percent of patients that received the DePuy ASR hip implant had to undergo corrective surgery for the defective device.
Colson Hicks Eidson – Injury Attorneys